Blau CA - Search Results

1

JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.

Miller CP, Thorpe JD, Kortum AN, Coy CM, Cheng WY, Ou Yang TH, Anastassiou D, Beatty JD, Urban ND, Blau CA. Miller CP, et al. Among authors: blau ca. Cancer Immunol Res. 2014 Apr;2(4):301-6. doi: 10.1158/2326-6066.CIR-13-0189. Epub 2014 Jan 15. Cancer Immunol Res. 2014. PMID: 24764577 Free PMC article.

2

Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.

Miller CP, Urban N, Blau CA. Miller CP, et al. Among authors: blau ca. Anticancer Res. 2011 Apr;31(4):1189-95. Anticancer Res. 2011. PMID: 21508364 Free PMC article.

3

Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.

Miller CP, Lowe KA, Valliant-Saunders K, Kaiser JF, Mattern D, Urban N, Henke M, Blau CA. Miller CP, et al. Among authors: blau ca. Stem Cells. 2009 Sep;27(9):2353-61. doi: 10.1002/stem.156. Stem Cells. 2009. PMID: 19544471 Free PMC article.

4

Sparse expression bases in cancer reveal tumor drivers.

Logsdon BA, Gentles AJ, Miller CP, Blau CA, Becker PS, Lee SI. Logsdon BA, et al. Among authors: blau ca. Nucleic Acids Res. 2015 Feb 18;43(3):1332-44. doi: 10.1093/nar/gku1290. Epub 2015 Jan 12. Nucleic Acids Res. 2015. PMID: 25583238 Free PMC article.

5

Using gene transfer to circumvent off-target effects.

Miller CP, Blau CA. Miller CP, et al. Among authors: blau ca. Gene Ther. 2008 May;15(10):759-64. doi: 10.1038/gt.2008.43. Epub 2008 Mar 20. Gene Ther. 2008. PMID: 18356813 Review.

6

The proteomic landscape of triple-negative breast cancer.

Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J. Lawrence RT, et al. Among authors: blau ca. Cell Rep. 2015 Apr 28;11(4):630-44. doi: 10.1016/j.celrep.2015.03.050. Epub 2015 Apr 16. Cell Rep. 2015. PMID: 25892236 Free PMC article.

7

Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progression.

Miller CP, Valliant-Saunders K, Blau CA. Miller CP, et al. Among authors: blau ca. Transl Oncol. 2010 Jun 1;3(3):176-80. doi: 10.1593/tlo.09304. Transl Oncol. 2010. PMID: 20563259 Free PMC article.

8

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.

Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau CA, Emery DW. Belay E, et al. Among authors: blau ca. Blood. 2015 Feb 5;125(6):1025-33. doi: 10.1182/blood-2014-02-555318. Epub 2014 Oct 24. Blood. 2015. PMID: 25343958 Free PMC article.

9

The Proteomic Landscape of Triple-Negative Breast Cancer.

Lawrence RT, Perez EM, Hernández D, Miller CP, Haas KM, Irie HY, Lee SI, Blau CA, Villén J. Lawrence RT, et al. Among authors: blau ca. Cell Rep. 2015 May 12;11(6):990. doi: 10.1016/j.celrep.2015.04.059. Epub 2015 May 12. Cell Rep. 2015. PMID: 28843283 Free article. No abstract available.

10

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.

Lee SI, Celik S, Logsdon BA, Lundberg SM, Martins TJ, Oehler VG, Estey EH, Miller CP, Chien S, Dai J, Saxena A, Blau CA, Becker PS. Lee SI, et al. Among authors: blau ca. Nat Commun. 2018 Jan 3;9(1):42. doi: 10.1038/s41467-017-02465-5. Nat Commun. 2018. PMID: 29298978 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters